On the way to find a cure for Long COVID, there is still much to learn about the condition. Currently, numerous clinical trials in Switzerland, Austria and Germany are addressing Long COVID. By participating in a clinical trial, you can contribute to Long COVID research, help treatments reach patients faster and possibly receive an intervention that helps your own recovery.
The more science learns about Long COVID, the better the resulting treatments.
In Switzerland, four clinical trials are currently recruiting patients:
- Basel Long COVID-19 Cohort Study (BALCoS). University Hospital Basel (schnepper@usb.ch, gunther.meinlschmidt@unibas.ch)
- Responses to CPET in Subjects With Persistent Exercise Intolerance After COVID-19: an Open-Source Exercise Network. Geneva University Hospital and many other French-speaking cities worldwide (contact@accpp.fr, recherche@accpp.fr)
- Pycnogenol in Post-COVID-19 Condition. University of Zurich (rasi@uzh.ch, thomas.radtke@uzh.ch)
- Sequelae of COVID-19 With Focus on Exercise Capacity and Underlying Mechanisms. University of Basel (schmidt-trucksaess@unibas.ch)
In Austria, seven clinical trials are looking for participants. One of them is also recruiting in Germany:
- Post-COVID-19 Outpatient Care and Biomarkers. Medical University of Vienna (gyongyosi@meduniwien.ac.at, christian.hengstenberg@meduniwien.ac.at)
- Neurological Outcome After SARS-CoV-2 Infection. Medical University Innsbruck (helbok@tirol-kliniken.at)
- To Investigate Efficacy, Pharmacodynamics, and Safety of BC 007 in Participants With Long COVID. Berlin Cures GmbH (info@berlincures.com)
- Chronic Stress as a Risk Factor for Long COVID (StressLoC). Medical University of Graz (fazekas@medunigraz.at)
- Vagus Stimulation in Female Long COVID Patients. Medical University of Vienna (helbich-poschacher@meduniwien.ac.at)
- Prospective Multidisciplinary Post-COVID-19 Registry Tyrol. Medical University Innsbruck (loeffler@i-med.ac.at)
- Effects of a Home-Based Exercise Intervention in Subjects With Long COVID. University of Vienna (sick@univie.ac.at)
In Germany, 11 clinical trials are already recruiting, while two are about to start:
- Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome. Jena University Hospital (egiamarel@med.uoa.gr) – not yet recruiting
- Study to Investigate Improvement in Physical Function in SF-36 With Vericiguat Compared With Placebo in Participants With Post-COVID-19 Syndrome. Charité University, Berlin (bellmann-strobl@charite.de, susen.burock@charite.de) – not yet recruiting
- To Investigate Efficacy, Pharmacodynamics, and Safety of BC 007 in Participants With Long COVID. Berlin Cures GmbH (info@berlincures.com)
- Effects of Inpatient Rehabilitation Measures in Long-COVID-19 Syndrome. Paracelsus Harz Clinic Bad Suderode (schlitt@pkd.de, viktoria.heinze@pkd.de)
- Sequelae of Sars-CoV-2 Infections. University of Giessen (matt@innere.med.uni-giessen.de, khodr.tello@innere.med.uni-giessen.de)
- Low-field Magnetic Resonance Imaging in Pediatric Post Covid-19. University of Erlangen-Nürnberg Medical School (knieling@uk-erlangen.de)
- Immunoadsorption in Patients With Chronic Fatigue Syndrome Including Patients With Post-COVID-19 CFS. Charité University, Berlin, Germany (pruess@charite.de, hannah.pressler@charite.de)
- Methylprednisolone in Patients With Cognitive Deficits in Post-COVID-19 Syndrome (PCS). Charité University, Berlin, Germany (franke@charite.de)
- Repeat Immunoadsorption Post Covid ME/CFS. Charité University, Berlin, Germany (burock@charite.de)
- Hyperbaric High Pressure Oxygen Therapy in Post-COVID Syndrome and ME/CFS. Charité University, Berlin, Germany (fatigue-centrum@charite.de, kim@charite.de)
- Munich ME/CFS Cohort Study. Technical University of Munich (behrends@mri.tum.de, kirstin.mittelstrass@mri.tum.de)
- Munich Long COVID Registry Study for Children, Adolescents and Adults (MLC-R). Technical University of Munich (behrends@mri.tum.de, daniela.schindler@tum.de)
- Visualizing Regional Lung Ventilation in Patients With Postacute-COVID-19. Jena University Hospital (reuken@med.uni-jena.de, jan-christoph.lewejohann@med.uni-jena.de)
